Condition
Diabetes Mellitus, Type 1
Locations
Germany, Italy
Start date
28/08/2025
Identifiers
Trial ID NN1436-8404,
NCT number NCT07160816,
Eudract number Not Available
NCT number NCT07160816,
Eudract number Not Available
Summary
The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.
Trial Overview:
Treatment
DRUG: Insulin icodec
Study type
OBSERVATIONAL
Trial duration
Aug 28 2025 - Jan 20 2027
Participants
245
Phase
Not Available
Are you eligible?
Gender
Male and female
Age
18 years and older
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.